Identification of Hub Genes and Immune Infiltration in Coronary Artery Disease: A Risk Prediction Model
Wenchao Xie,Wang Liao,Hongming Lin,Guanglin He,Zhaohai Li,Lang Li
DOI: https://doi.org/10.2147/jir.s475639
IF: 4.5
2024-11-13
Journal of Inflammation Research
Abstract:Wenchao Xie, 1, &ast Wang Liao, 1, &ast Hongming Lin, 2 Guanglin He, 2 Zhaohai Li, 2 Lang Li 1 1 Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China; 2 Department of Cardiology, The First People Hospital of Yulin & The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, 537000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lang Li, Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China, Email Purpose: Our study aimed to establish a prediction model for coronary artery disease (CAD) that integrates immune infiltration and a gene expression signature. Methods: 613 differentially expressed genes (DEGs) and 12 hub genes were screened via the GSE113079 dataset. The pathway enrichment analysis indicated that these genes (613 DEGs and 12 hub genes) were closely associated with the inflammatory and immune responses. Based on the differentially expressed miRNA (DEmiRNA)-DEG regulatory network and immune cell infiltration, the Lasso algorithm constructed a CAD risk prediction model containing the risk score and immune score. Then, ROC-AUC and polymerase chain reaction (PCR) were performed for validation. Results: Six hub genes (PTGER1, PIK3R1, ADRA2A, CORT, CXCL12, and S1PR5) had a high distinguishing capability (AUC > 0.90). In addition, the miRNAs targeting 12 hub genes were predicted and intersected with the DEmiRNAs, and the DEmiRNA-DEG regulatory network was then constructed. Two LASSO models and a novel CAD risk prediction model were constructed through LASSO regression analysis, and they both accurately obtained the risk of CAD. The CAD risk prediction model shows good performance (AUC = 0.988). We also constructed a valid nomogram, and PCR results verified three downregulation hub genes and one upregulation gene in the CAD risk model. Conclusion: We demonstrated the molecular mechanism of the hub genes in CAD and provided a valuable tool for predicting the risk of CAD. Keywords: coronary artery disease, DEmiRNA-DEG regulatory network, nomogram, immune score, immune infiltration Coronary artery disease (CAD), which results from atherosclerosis, is a common cardiovascular disease. Hypertension, diabetes, obesity, and smoking are the main factors that induce CAD. 1,2 As a major cardiovascular disease affecting the global population, CAD has been demonstrated to be the leading cause of death in developed and developing countries. 3 The prognosis of CAD remains unfavorable due to slow death from deteriorating cardiac function, sudden ventricular fibrillation, or atherosclerotic plaque rupture. 4,5 In the case of CAD, coronary angiography (CAG) is considered the gold standard of diagnosis, but its application is limited due to its high cost and invasiveness. In contrast, blood biomarker detection exhibits marked advantages, such as lower cost and less invasiveness. 6 The diagnosis of CAD is often based on a variety of blood markers, including myocardial injury markers (myocardial enzyme, troponin), inflammatory markers (C-reactive protein [CRP]), blood lipid indicators, and homocysteine Hcy. 7 Many studies have confirmed that CRP is an independent factor for predicting primary and secondary CAD events. 8 Dyslipidemia is considered a key risk factor for atherosclerosis. Small and dense low-density lipoprotein (sdLDL) is often observed in the serum of patients with atherosclerosis. 9 Lipoprotein (a), another cardiovascular risk factor, has multiple effects on atherosclerotic cardiovascular disease (ASCVD). 10 These markers provide essential clues for diagnosis. Still, it should be noted that they cannot be used as the basis for diagnosis alone and should be combined with clinical manifestations and other examination methods. In addition, microparticles (MP) and exosomes, as emerging biomarkers, have shown great potential in treating various diseases. 11 Exosomes play a central role in atherosclerosis because they are deeply involved in lipid metabolism. However, although exosomes are closely related to atherosclerosis, the detailed mechanism of the specific goods (ie, contents) carried by exosomes in atherosclerosis is still largely unknown. Recently, microarray and high-throughput sequencing are now widely applied to predict potential therapeutic targets for atherosclerosis. 12 Furthermore, these methods can be used to identify biomarkers that can be applied to diagnose and treat CAD. -Abstract Truncated-
immunology